Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of a significant growth in short interest during the month ...
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), ...
1d
Zacks Investment Research on MSNBristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on ItBristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
1don MSN
We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...
Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally.
High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on a high yield can be dangerous because if it ends up getting cut, you could ...
Shares of Bristol Myers Squibb Co. BMY shed 2.36% to $59.55 Tuesday, on what proved to be an all-around mixed trading session ...
Learn more about whether Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...
A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.
Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...
BioReference Health, a biotech company, is laying off 81 employees at its main laboratory in Elmwood Park. The move comes ...
1d
Zacks.com on MSNWill Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results